A UNIQUE CASE OF 3 AUTOGRAFTS FOR ACUTE MYELOGENOUS LEUKEMIA WITH SUBSEQUENT LONG-TERM SURVIVAL IN 2ND REMISSION

被引：0
|
作者：
LIM, SH [1 ]
MCMILLAN, AK [1 ]
GRIBBEN, J [1 ]
GALVIN, MC [1 ]
GOLDSTONE, AH [1 ]
机构：
[1] UNIV COLL HOSP LONDON,DEPT HAEMATOL,GOWER ST,WC1 LONDON,ENGLAND
来源：
LEUKEMIA & LYMPHOMA | 1991年 / 5卷 / 2-3期
关键词：
AML; DURABLE SECOND REMISSION; 3; ABMT;
D O I：
10.3109/10428199109068127
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
We report here a patient with acute mycloid leukaemia who relapsed 20 months after undergoing a double autograft procedure in first remission. He was reinduced and subsequently underwent a third autologous bone marrow transplantation in second remission using bone marrow harvested in second remission and a Busulphan and Cyclophosphamide conditioning regimen. Although the engraftment was very slow, he has remained in second remission for 34+ months. This case demonstrates that durable disease-free survival can be attained by a second preparative therapy, even in second remission, for patients relapsed after autologous bone marrow transplantation. © 1991 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.
引用
收藏
页码：207 / 209
页数：3
相关论文
共 50 条
  • [1] LONG-TERM 2ND REMISSION IN ACUTE-LEUKEMIA OF CHILDHOOD
    HANSEN, HG
    GRAUCOB, E
    [J]. KLINISCHE PADIATRIE, 1979, 191 (01): : 96 - 101
  • [2] LONG-TERM REMISSION IN ACUTE MYELOGENOUS LEUKEMIA
    BUCHNER, T
    URBANITZ, D
    FISCHER, J
    HIDDEMANN, W
    RUHL, H
    EMMERICH, B
    HEINECKE, A
    PFREUNDSCHUH, M
    WENDT, F
    [J]. LANCET, 1984, 1 (8376): : 571 - 571
  • [3] Duration of first remission predicts remission rates and long-term survival in children with relapsed acute myelogenous leukemia
    K Stahnke
    J Boos
    C Bender-Götze
    J Ritter
    M Zimmermann
    U Creutzig
    [J]. Leukemia, 1998, 12 : 1534 - 1538
  • [4] Duration of first remission predicts remission rates and long-term survival in children with relapsed acute myelogenous leukemia
    Stahnke, K
    Boos, J
    Bender-Götze, C
    Ritter, J
    Zimmermann, M
    Creutzig, U
    [J]. LEUKEMIA, 1998, 12 (10) : 1534 - 1538
  • [5] LONG-TERM SURVIVAL IN ACUTE MYELOGENOUS LEUKEMIA - A 2ND FOLLOW-UP OF THE 4TH INTERNATIONAL WORKSHOP ON CHROMOSOMES IN LEUKEMIA
    SWANSBURY, GJ
    LAWLER, SD
    ALIMENA, G
    ARTHUR, D
    BERGER, R
    VANDENBERGHE, H
    BLOOMFIELD, CD
    DELACHAPPELLE, A
    DEWALD, G
    GARSON, OM
    HAGEMEIJER, A
    MITELMAN, F
    ROWLEY, JD
    SAKURAI, M
    [J]. CANCER GENETICS AND CYTOGENETICS, 1994, 73 (01) : 1 - 7
  • [6] IS CHEMOTHERAPY OR TRANSPLANT BETTER IN ACUTE MYELOGENOUS LEUKEMIA (AML) IN 2ND REMISSION
    GALE, RP
    REES, JKH
    GRAY, RG
    HOROWITZ, MM
    [J]. EXPERIMENTAL HEMATOLOGY, 1991, 19 (06) : 572 - 572
  • [7] INTERLEUKIN-2 AS MAINTENANCE THERAPY FOR ACUTE MYELOGENOUS LEUKEMIA IN 2ND REMISSION
    DUTCHER, JP
    WIERNIK, PH
    TODD, M
    CALIENDO, G
    BENSON, L
    [J]. EXPERIMENTAL HEMATOLOGY, 1993, 21 (08) : 1048 - 1048
  • [8] ACTIVE IMMUNOTHERAPY IN ACUTE MYELOGENOUS LEUKEMIA AND INDUCTION OF 2ND AND SUBSEQUENT REMISSIONS
    HARRIS, R
    ZUHRIE, SR
    FREEMAN, CB
    TAYLOR, GM
    MACIVER, JE
    GEARY, CG
    DELAMORE, IW
    HULL, PJ
    TOOTH, JA
    [J]. BRITISH JOURNAL OF CANCER, 1978, 37 (02) : 282 - 288
  • [9] LONG-TERM REMISSION IN ACUTE LEUKEMIA
    KORCHMAR.IF
    SEDYKINA, EI
    TERESHCH.PV
    [J]. TERAPEVTICHESKII ARKHIV, 1974, 46 (08): : 47 - 48
  • [10] LONG-TERM REMISSIONS IN ACUTE MYELOGENOUS LEUKEMIA
    POWLES, R
    [J]. LANCET, 1984, 1 (8380): : 800 - 801
12345